Moving medicine and science forward
In our lifetime: the race to outpace Alzheimer’s
The “In Our Lifetime” video series from WashU Medicine explores Alzheimer’s research and the hope it provides to millions around the world through the eyes of four participants.
New approach to designing drugs supercharges cancer medication (Links to an external site)
Shape-shifting drug hits tumors in multiple ways, improves outcomes in mice.
Dementia rising across Latino populations, multidecade study finds (Links to an external site)
Cases climbed in Mexico, Peru and Puerto Rico over two decades, bucking a downward trend seen in many wealthy nations.
Global consortium launches AI tools to accelerate Alzheimer’s research, treatments (Links to an external site)
Founding members include WashU Medicine, pharmaceutical companies, philanthropic groups and others.
Aid for brain-bleed recovery receives FDA Breakthrough Device Designation (Links to an external site)
Earbud-like device from WashU startup Aurenar is designed to improve stroke outcomes after ruptured brain aneurysm.
Faster aging in younger generations linked to rise in early-onset cancer (Links to an external site)
Immune system aging linked to earlier lung cancer; fat tissue aging linked to earlier colorectal cancer.
Researchers find a common weakness in major gut pathogens (Links to an external site)
The discovery could lead to a single vaccine against E. coli, Shigella and other causes of severe diarrhea.
Research Wire
Nasal spray vaccine protects against bird flu in mice
Researchers led by Jacco Boon, PhD, found that a novel H5N1 vaccine confers robust protection regardless of prior seasonal flu immunity.
Scientists identify genes that could reduce APOE4 Alzheimer’s disease risk
A research team led by Michael E. Belloy, PhD, identified key genetic targets for potential Alzheimer’s disease therapeutics development.
Stitziel receives grant to study genetic drivers of cardiovascular disease
Nathan Stitziel, MD, PhD, has been awarded $1.9 million from the Leducq Foundation to help identify new therapeutic targets for cardiovascular disease and improving prevention.
Four researchers receive Siteman Catalyst Awards
The awards will support research on brain sparing radiation, smarter leukemia drugs, better BRCA1 risk prediction and new strategies against aggressive pancreatic cancer.